Aging Biomarker p16 Predicts Risk of Peripheral Neuropathy in Women Receiving Adjuvant Taxanes for Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
NPJ breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
NPJ Breast Cancer 2022 Sep 08;8(1)103, N Mitin, KA Nyrop, SL Strum, A Knecht, LA Carey, KE Reeder-Hayes, E Claire Dees, TA Jolly, GG Kimmick, MS Karuturi, RE Reinbolt, JC Speca, EA O'Hare, HB MussFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.